netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Formulary Chapter 14: Immunological products and vaccines - Full Chapter
Notes:

Please refer to the Public Health England Green Book on vaccines for the most up to date information on the recommended preparations and use.

The use of travel vaccines in primary care is not recommended in line with NHS England Guidance on items which should not routinely be prescribed in primary care
 Details...
14.04  Expand sub section  Vaccines and antisera
 link Link    MHRA Drug Safety Updates: COVID-19 Vaccines
14.04  Expand sub section  Anthrax vaccine
14.04  Expand sub section  BCG vaccines
14.04  Expand sub section  Botulism antitoxin
14.04  Expand sub section  Cholera vaccine to top
14.04  Expand sub section  COVID-19 vaccine
14.04  Expand sub section  Diphtheria vaccines
14.04  Expand sub section  Haemophilus influenzae type B vaccine
14.04  Expand sub section  Hepatitis A vaccine
14.04  Expand sub section  Hepatitis B vaccine to top
Hepatitis B vaccine
View adult BNF View SPC online View childrens BNF 		Formulary
Green 		 
 
14.04  Expand sub section  Human papilloma virus vaccine
14.04  Expand sub section  Influenza vaccine
14.04  Expand sub section  Measles vaccine
14.04  Expand sub section  Measles, Mumps and Rubella (MMR) vaccine
14.04  Expand sub section  Meningococcal vaccines to top
14.04  Expand sub section  Mumps vaccine
14.04  Expand sub section  Pertussis vaccine
14.04  Expand sub section  Pneumococcal vaccines
14.04  Expand sub section  Poliomyelitis vaccines
14.04  Expand sub section  Rabies vaccine to top
14.04  Expand sub section  Rotavirus vaccine
14.04  Expand sub section  Rubella vaccine
14.04  Expand sub section  Smallpox vaccine
14.04  Expand sub section  Tetanus vaccines
14.04  Expand sub section  Tick-borne encephalitis vaccine to top
14.04  Expand sub section  Typhoid vaccines
14.04  Expand sub section  Varicella-zoster vaccine
14.04  Expand sub section  Yellow fever vaccine
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Red

 Drugs for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician and the drug should be supplied through the hospital throughout the duration of treatment. In some very exceptional circumstances (e.g. due to distance from the hospital, storage, supply or mobility/transport problems) it may be appropriate for the GP to be asked to prescribe a Red drug. This should be negotiated on an individual patient basis and should only be done with the GP’s prior informed agreement where the roles of the GP and hospital services are clearly defined and agreed. The GP should not feel under pressure to prescribe in these circumstances. For all RED drugs automatically added to the formulary in response to a positive NICE TA: Prescribers need to ensure that local Trust new drug governance procedures and pharmacy processes are followed before any prescribing.  

Amber

 Drugs initiated by hospital specialist, but where continuing treatment by GPs may be appropriate under a shared care arrangement. The specialist should send the GP a copy of the shared care agreement to sign. The GP should sign the shared care agreement, or indicate they do not want to be part of such an agreement, and return a copy back to the specialist. Shared care guidelines are available or are being developed for most of the drugs listed as Amber. If no shared care guideline is available, the hospital specialist should provide the patient’s GP with sufficient information and support to allow treatment to be continued and managed safely in primary care.  

Green plus

 Drugs normally recommended or initiated by a specialist (hospital or GP with an extended role https://www.rcgp.org.uk/gpwer), but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case. Provision of additional information, or an information leaflet, may be appropriate in some cases to facilitate continuing treatment by GPs.  

Green

 Drugs where prescribing by GPs is appropriate. Can be initiated and prescribed in all care settings, and if appropriate, discontinued without recourse to secondary care.  

Black

 NOT APPROVED: Drugs that have been considered by NTAG or the NENC ICB Medicines Subcommittee (or other approved body) and are not approved for prescribing within the North East and North Cumbria.   

Brown

 UNDER REVIEW: drugs whose current formulary status or RAG status is currently under review.  

Not Recomended

 NOT REVIEWED: Drugs that haven not been reviewed yet. This usually means that an application is in progress. These drugs are not normally considered appropriate for prescribing in the North East and North Cumbria until such time that a decision is taken on their formulary status.  

netFormulary